United-Guardian, Inc. (UG) 股票分析

公司概述

United-Guardian, Inc. operates as a specialized manufacturer and marketer of cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients within the United States and international markets. The company is categorized within the Consumer Defensive sector and specifically functions in the Household & Personal Products industry, positioning it as a provider of essential goods that maintain consistent demand regardless of broader economic cycles. As a publicly traded entity with a market capitalization of $30.37M, the firm operates on an annual revenue base of $10.55M, while its total employee count is not disclosed in available records. These valuation and revenue figures indicate that United-Guardian functions as a small-cap enterprise, suggesting a niche market position where the company leverages specialized product lines like LUBRAJEL to capture value in a specific segment of the personal care and medical supply chains rather than competing through mass-scale volume.

财务健康

The company reported a total revenue of $10.55M over the trailing twelve months, with a corresponding net income of $2.11M and an EBITDA of $2.35M. The gap between the $10.55M revenue and the $2.11M net income reveals a cost structure where operating expenses and taxes consume approximately 80% of gross sales, though the gross margin provides a buffer against these downstream costs. United-Guardian generated free cash flow of $845,767, which indicates a significant degree of financial flexibility allowing the firm to fund operations without immediate reliance on external financing. The company's profitability is reflected in three distinct margin metrics: a gross margin of 48.8%, an operating margin of 24.4%, and a profit margin of 20.0%, all of which suggest efficient production processes and pricing power in its specialty ingredient portfolio. Regarding liquidity and leverage, the company holds $8.57M in cash against $0 in debt, resulting in a debt-to-equity ratio that is effectively N/A, which characterizes the balance sheet as highly conservative and free of financial distress risk. Furthermore, a current ratio of 7.31 demonstrates robust short-term liquidity, implying that the firm possesses ample current assets to cover its current liabilities many times over. Return on Equity stands at 18.2% while Return on Assets is 10.4%, metrics that collectively reveal management's effectiveness in generating returns on the capital employed and assets held within the business.

估值评估

United-Guardian, Inc. carries a trailing P/E ratio of 14.37, while the forward P/E ratio is not available in the current data set, a discrepancy that implies market expectations regarding future earnings trajectory cannot be quantified via price-to-earnings multiples at this time. The stock trades at a price-to-book ratio of 2.70, indicating that the market values the company at a significant premium over its tangible book value, likely reflecting the intangible value of its proprietary cosmetic and pharmaceutical ingredient portfolios. Alternative valuation metrics provide further context, with a price-to-sales ratio of 2.88 and an EV/EBITDA of 9.27, suggesting that investors are willing to pay a moderate multiple for its sales relative to the broader industry averages. The stock has exhibited volatility within a specific range, trading between a 52-week high of $9.88 and a 52-week low of $5.58, placing the current trading price at a level that requires calculation relative to the high and low to determine precise positioning within this historical band. The beta value is recorded at 0.96, which indicates that the stock's price volatility moves in tandem with the broader market, presenting a risk profile that is roughly equivalent to the systematic risk of the overall equity market.

Growth & Income

The company has demonstrated strong expansion with a revenue growth rate of 19.6% and an earnings growth rate of 29.0% year-over-year, indicating that earnings are expanding at a significantly faster pace than revenue, which often implies improving operational leverage or cost efficiencies. United-Guardian is an active dividend payer offering a dividend yield of 7.6%, yet the payout ratio stands at 130.4%, a figure that suggests the company is currently distributing more in dividends than its reported net income supports, potentially utilizing cash reserves or prior retained earnings to maintain the yield. Given the payout ratio exceeding 100%, the firm is not relying solely on current earnings for dividend coverage, a strategy that carries inherent risk regarding sustainability if earnings do not accelerate or if cash flows decline. Summarizing the overall profile, United-Guardian presents a hybrid investment characteristic combining high-yield income attributes with double-digit earnings growth, though the elevated payout ratio necessitates careful monitoring of future cash flow generation capabilities to ensure long-term dividend stability.